INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138347, 5425, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05708f40856a85030d1b550284f4dcd2e06004eb506c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138348, 5425, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333130c84d5708f05708f4080600141a0334', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138349, 5425, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05708f40856a8503053284f4dcd2e0600438b0665', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138350, 5425, 400.0, 400.0, 'mg', 'PO', 2, 'Adult', X'789c333130c84d5708f05770f27451a8503034d035b2504849ac2c060051130698', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138351, 5425, 5.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf34bcdcf4b2c492db65230d5553034c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4d03534ca000021f70d36', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138352, 5425, 10.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf3cc4b4bcc2b29b6523034d03532c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4d03534ca0000120c0cd9', X'789ced196b6fdbc8f1af0c0c04480049a6a897251f50c852ceced576749693a23805c28a1c915b93bbeceed23673c87fbf59522f2a8a25a7e9e18ada1f64923bef3787bf1ff92a0da682c578d483a3018fd1709f0b3caac051aa22fb303426d1bde3e3077e87714daac05ef1e332acf6144bd09f3263515cc76d579d7ab5eedc3a9d5ecbe935dc9ae3b4dc763d8745cf70293441fe7e748e02158bf26b838f39fa6d96606f222e5c9845d2bb43351143a95980f0b354b1ee81eb381568d89fa6fd39719c389888818c6329e056311fe19a5422c85b16d085818b338b94734f679b027ca14786cd22b477bf7da2bb888bbbfc662dd05a92fd76b970a74bd82f9f2cf5be9f46664a0a701194d4dc21cdd130953e0a164d3f441eaacab44f67f75842cbb585d17bf8f5620c8fd0ac9ec00322895cd6c4b2dea676c5b830f440786592cd0d923bc89c336d14f79654582ed374868207e229d1dadf14eca2361d6591547cfa4ecc0bfd770b74f66e4884ea4ed53d019f655fd17ac27d3b2df04c7bee73cf8b410fb5c0b625ff874df00344dfb6c69f26fb7fc4e8f0d299f31aa1cf596ea9038bdff9db9be1f1e8c3b004788d5230636b79ab4af2c4c1f15d704c1259217d7ecf7df4e1df27d5ba1b4e04e9c48421502bf7d3a0839047be42619b49b5f90dd8f6c5b363e3afa9c2333d374ed0e394e32399a4115b3b68a9d0486160533e831b3a15d47b7b7006af99e0318b409bd4e7a84187f2018404c5f51dcca502e6dfa3d20873340486731b80ba02611a33b1781832154322b5e6241dcc5203a988a8c146d99b89b8a454cba5e9c148c9192990c198cd71226e6c498222cc2622efb83d18a8c1a53523cd1fe0a3a790116f5fd24fcb7955b1c711fc54a7f9a17cd869bd9a8855ecf60ab8dcc2db906eeb15905a01a53f3925ac141c7f7277f1a371061312dedb96f25a1a18e29ce6287f832dd9cd1091fcf1f74e2ddb5eda3fbb0ced305800eb2917d31585c5283390c2282af83ef77644453f8a50051918095ec4b43eb6b3e544782cb5b0c0e7a07237f138615cc5284ce9305cd867e7b1008c7c54e4700b4467ba84eb854a0ac2a570a51190a98c12405bfb6f42d1147955c2e2719c0ae9c938513226f8efb6f4f0ea00db5eade6c13c0ba637c8bcaf8db8ab2e8e5171996e195b90ad4249c290cd4973231fb9c74d36110253a36442ed884d8421c3c433e96566f984058a8934ca1f694e66640939cb1a9e098c2d444214c88af6d2c7442125a314f45867c43047095914a51e174510d011c50885bbe1c69eda814011459bcf029350158f673497671e537e2e17f3c2d54dff63315e4f84be234fab856176f4f862c42f192244e61331f234d1528a6eedd5e7cf64184d5c834c2079d86a480782a5da02dc93bf8bc2e549314f0b0559c08bf24204947cd00b0a8a692ab6fdcbdb4a7f7c4b6188f76c97740705cab7bcb63f7cb630a72b4ce2bba6bfe1fbfd24af37804b54b683663fa9db6d8c12bd5540ed27345a819628ace3f080445bc396a558c6ef0152ac404b14ca617fc0ab6019be2ccd46ca1c20d0267489ce4656ed2773b6015cf6f83a1d0f70f6067089ca328f0f88e68fc54bf2967d17a97c80659790e52859148003626409b985bf281b8710588296f32faf2f07a45e0157c25dd6a4fdd81f9790257c5ba7f6e3de58a8a211fd1fb795ed0efbd2575efaca4b5f79e92b2f7de507f495bf5831fd9e17ba9788f953236664d73ecc93910cb252dc50a59b57233ec71eb817137185e439ea553aeec125a7d7e85318fc73d46c3915a8f7dd0ab8837a977e876d7827423ee346aa8978fb4825aed81aa58a2c65c97821134405e41cfa5e7176c1b561319dc3850b37e86142d89b9f7d9ebb43439cf6232dbf1aafc225230adba7faf6f7c46d99fe61dd7f03be5c75ff0b33456e991b9ca342e16179f4749d7a17fa310da51e13704efff34d9886b1f4389a0cce90e63f18d0dc67cfe043e23383f0f6314165803a1946b527f1730605960ffdf3f13641bba21c4983243d35d88c628825090d329610c2152eb75ef041a3dd48bdb71b29c8d778ba06bf10ef2557cbb296f33b6d775e37dff4da9d66b5dd6dd6c097dcae766b75fa3bfe57a06bf556a7dda9c16fa374461ca0e1b4bb8d6eb3fd896263a9ca527e1bace425132295424a15f29b865ba6efec67510f81247b3fd306f3fde10a92d560a4ece44b1041ca7db46ed1b9b27205cd56d03dba86746124858924dbce32a043f8710295b0326b29a7735a77dad65427cd46f5a4dd589ba4de69d61b5db7614d42351ff11ede56e0ef5226766d7c5581bee2fa335c1259bb6ace5d63df3d6206c56c236c529b9019e03adfab32d03c1056fc622139673c4a15d5988790e216ecda528355748604a113ca40bb8efe1bf9f89d7d091136186a50ef76bba76eb3fdbaf1a6e7363b55b7e56e48ed343bad6ed7b5528f2f46701ba2fd429eda37a2f3b51bc8446363c74ac8bf26d9bd761266117be4145239a2eda63c1f3b2df006194d9ef2210fd17b62b87492c53993344559fd865c5109912a67744d70f18c98d49b152bfc894d17d2895a58644218679ad2c856e2856aaddc1f0dd2acd1e96e6ad6ee3a6ebd6b355352c8f91cce6f2a944cf48a680cfce3ca5e2ba1e197710590ac1dd13f9fd4b1db655210b5a7a8368bc03aaa58dcffbc7440b11bdf34908dd322c5727597df3c6ad02291ad1746f48411741272568151bfb78ed3818c220cd01a6214669a6a1013fa348fb6da732bfa972f7f00b26d323a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138353, 5425, 20.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cec8cc49294acdb3523032d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834f30000fa2d0c80', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138354, 296, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303235c84dd7513035005200730007f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138355, 296, 500.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c333530c84d5708f05770f274010013ec0318', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138356, 296, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c333235c84d572834d3b5c8000011580300', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138357, 296, 5.0, 5.0, 'mg/kg', NULL, 2, 'Pediatric', X'789c33cd4dd7cf4e5770f2740100111302fa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138358, 11118, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138359, 11718, 50.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cc2bcecfcdcb4cb4523035d0353430c84d5708f057482c51484a4d29c9cc4d0500a6b20a3e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138360, 11718, 150.0, 600.0, 'mg', 'IN', NULL, 'Adult', X'789c73492d284a2d2ececccfb352303435d035333050c84dd74f49ac54c8cc5348c92ccb4c494d5148c92f4e2d060034570e5f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138361, 2294, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b65228494cca492db152303235c84dd75130350052d60af94589390ac5a5c505a979c599f979560a8646a6b9e9faa6b93e3a1095202600f26318bd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138362, 2294, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353530c84d5708f057283434ca50a8503034504849ac2c06005c290733', X'789ccd566d6fdb3610fe2b07030556c0ae65076e066d5fdc744387b55d90649fa642a0c993c4993a6a24955a29f2df7794f326c75b9aa02dfac526a9e33d0f9f3b1eefd348b9b6cc49d4384a61748445e3ec8536a3318c5a67e25a1542e3d3e9f4a35e63fdc2ba328ef47460eaa5130daa5c84b8639ecc5f4e92d964969c2587e9224993d98b83c3c31f93796f8b32684b9e2d3f8d96aad6a47d7022aef54b0137bd97b3aec114e6a4a044c2ad4146129b4a18eb1beb344f5f5b2f4a845fadab7d0a41ac0c863158270cf8d63748bedf7565761a1c5219aa1b53f6bf48ea720c8b84ff7edadd98c26cbea8cbe9a27e3bde5ac6614627b60de8c11630e49fc2f11f191dd9bab604674e2884f7ac2cc3b15ad752b5abbb0a5cf252cf25cefefac033a369dd4f6ea5181cfa734273d7fcf243c458aad6849c75d0540e64fe8d8a2b3a63580919d06961d28cf8b8935e153e13fc339b57b08159024a74fe71c7e8e18f5169119c96fb28e8ffa07010055f9753c68c24943ed70ad50e9931d4224e22d568f90472a70d4a46cc8f6dd31a719b9cd7fc8e1d9624487670c25fa9cc38d0af327acb547b6b70daafe3225f8815e374e045817b888c4e9018678f047d78384ddc91819fe1204941a174283c82b2fcb3489e65742362fa7f76a3e169e301df60c344f76a7f054c96d803169a50dd051a7cd8f5fc59b9bb2bdec3e9fb3a56a4adb1cf35e5371e460c78eb7828ffc36e6fecf3689f4b11b0e40bc2e4b737e45bc5663727be7d70be744e3cf2ba1d59e27aa94969b9e7b22d8d415776102c4823bc9fc6078ae17ffff309504b758ece637e8242de87da178d532e3eb61dda09124dd519b1d13e238ffaa275c823e232eb6cb01b2d75e83232d8ae2dbf1c5af03b0281bfd52b2bbbb05de39d01cf91267fdb8a3c67adef48b109f29b3651ba28800f6bb90e052e712cb573158a3d7779fbba0cf891683d32c0f5ae8cce6dadb7958a95262fe22315227ba52f2e386c9e874ef82a238ce1b74da58dbe87f660ddfceeb4da8de67724d657a6f2d8f7b812ae16d21a5b76034e6f8429264617dc7a71d3068cf40ed99135dad72954dba291d12f1bae6cdb96a72559092a39129aa0e58e03e18797b367cf9fc0ea1d46578c94db225fca7b2de1557320b51266cc70955ee9e041a231f051f04fdd4acea026709f10732654e8f5a3db95cbcb7f015fadcbb5', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138363, 2294, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca50a850303450004a14eb28e42682380620c5400100bc751058', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138364, 1760, 200.0, 200.0, 'mg', 'IV', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303235d0313530b056303230c84dd7cff5b156f00c0300bd5409d0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138365, 1760, 1.0, 1.0, 'g', 'PO', 2, 'Adult', X'789c3354485708f0d7f70c5348ca4c010016880395', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138366, 1760, 1.5, 1.5, 'g', 'PO', 2, 'Adult', X'789c33d43355485708f0d7f70c5348ca4c01001c2103f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138367, 1760, 1.5, 1.5, 'g', 'PO', 2, 'Adult', X'789c33d43355485708f05770f27451c82f523004f23cc3149232530053ac06b1', X'789ced5a6d6fdb3812fe2b03030552207e6d9d6c9dde02d9e4ee1ab4d91a49b7c0627d2bd0d248e2462205924a232cfadff721652776e26dcf4171ddeef94b6291c3e1cc332f9c11f57b2731751629517267429df326d655ce4a17c27154ea949d2c3afbd4a94de1e773e72a3be9f73fc82b2e7bda64fe97ecffe9321b1b51711209e7578f06a383ee60d81d0ede0d0e27e3c3c9f3716f34387c311a075a8e9dd4ca82f2f7ce71524a25ad33c28f8521c73781cbbba6e2099d9565adb4adabcab0b542b9993ad556644cffd2a6b4131a8d07fbe3c1e08846834199f5cb374774f67ea62e74edd8924e697d8b094ddfee078a135d965ad13b2312a61f010c989d70519c70e5829cf57c55d48f1872625eb07ffae53f782aa4ba6a1ffcdc7152172e826c52656b7a6ce0d5792d13c54d049994ad0a681519fead25882a038c9b42dc48bbc667481964ef9fbda7b94c66ead209e380cf7bfa205d4e52d1e8794e95b68eeed8ee53ac9593aa66aa2b729a86cf29118ddd278b5571ee87a66fe9f8f2780ad854aa2794c96b26e0c265e51ab24e9722ce8ff0c3eb4e154064e52c95a22127aeb8dd3dd53ae9ac03e43179c590714b2d7be3afa8e7061dde80ce3c4e07fae1ec94b4216fb9a53aede6d62bf51575aaabda468aabdc48b7d1cd5685ad6d6be599420c260825ad78a6827856266c28e1980588128d3fe3c11312a9c3f041a9a10e0b57c263ee4bf18970ba93e56ebfcfe7a6e91dedc7a0e4df35c6eee7925d90ed82ecab05d937e97cf72368e77ddfa8f7fd2d0cf7c01bff2f2cf77594fcef6bfa2fa4e79413299c91f117ee0ca2d11aa76754eaeef03b6a00163642df74d07643bf8e16501ed17181247b38c6f0d2fd53f8ff5c27f0c6daa43d12408afe41c3de68dcf56182c54734a44f927f7f4b782e6e269ebaef6db085436d53ab7d035a6fd9355e561c4b5144535dd585b87383a58a70a84c09153774815995cdd0c09eced41b11bb404d46da2b3f880465e5bc68a85656a49b44e95cb0c24e1bfc30b4ae9399ba0a56584973b7a5e83e22ac100d2794198416a5b50a8c499665f0700e19525713529a44f25b6d43cc7d9a275a741fbef798745769d9489d4c4ecc49412f47e3094ae29b609c60db57a7fde969d8d1bf1f28b8dd31f725894fed853f1d36ed8c3eff96e10796591e50eccf59712add0a5f07b553a91889e83690ffca382df47a366881ba8d863ecea6cd706d6cdafdce1b1356eb2864bc23ad8a1a4e4acb809b296f97437c90c57953823491d6a7e77b4a1f9176392cb45c21cb4a48e367fe14fbfff1d68f3a17ef87ece74f8d53ff6aae25b69154d12d870e36bc63bc1ef49f677b4b1f79fa2886e364da4808df9e4dbb7cb0cb079bf2c1c3170cbb84b07d42d8e5d287d06d591c9da0c73242aa44c61b4aa3e3a2609335bed58a0b616ddfdf7020dc1b38bf65657b7ea6d24563b599fb20f96e407b68eb50d0954f5142b18df3ee8f4d2e14d946254697e8295e735134dd4be6ac949effca542cea3674d1c315683a506b2d43726532a57f9f79a0b401c9da780bf702c3fd05ce6b1473f40d085463f407a0162e3c30b346327dfd13edf92b1814c4b01980edfa4e1420c1bf826af6e9a32e2fae3d68d1058bf821d29b92c2a5cf30f53a9dcb81d45cc70d121a2b2966aae0fa6af95b71edccf241ae5deb042da54adb0deeb0d155a58dabfded8d77ac25c14c5d4b032c4d90f65ab463ded468aa3155db2efc41c73d0a0da68699f206ae7ffe0654359c1b5d1ac5b0340938be0d8236659563f5f2179a8e42a6ecef8cd0b62fed0943230e647b38cf142c0d481150be2ec7031c0f1608e2f4eb220ef6071bf4b73325e2daf1c20752218bdaeb2715ba54e8e6d0025051c3820bf7088deea28a2850d9efd330bc7f90255bd7f255199074580789bcdd1711f2b09e6befb9d60c1562c42146d6819f21d2e07d3830b13fec0b3ff33073c21e18a1b8f4508979a24be9f5409cab200a54a8165658b578eacd180ee044c4399452029dbce85f637ddbcc248dadb80a16804c7a2112ed1951c9c4bf8301fdd3964c79a9625d67f922c6e35c17010dfc2b971caec4e2016d7fa98dc75d05a0ad2e21d3b6f97be7e57f592fbf9f90766efe7837df61b78edd96a7e73417f04c0481ce9a35105fc169bb3ec226343cecbdc8696ffa968cff32e1297cfda07790878aa41d99a973c62e08255b4eda66e5884e7e9e3e1fa37c6fdf83225e7d91e3df7b5e7beb24bec4296f3fca40f6103140d93b9f1e83dd3f6f62c3ed370fb541a5402f9e3da1bd97c327842e04654fc609c48061d9d2c19347e87dce9e0dc48d741a1dc70fbee0902a9773e92cfdd025a1127ad76dd30e5227d34aeec1b2ed37bf602c4669caebd9992b1d83276fca119f64f9f1e31fc3e462b4', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138368, 1760, 1.0, 1.0, 'g', 'PO', 2, 'Adult', X'789c3354485708f05748ca4c01000d7302c7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138369, 1760, 600.0, 600.0, 'mg', 'PO', 2, 'Pediatric', X'789c3356c8cdd735b450a8ccb75270c92f4eb552303330c84dd7cf8d335208f05748ca4cb15670cc29b1523037050a83849c3c5d14d2f28b1492f2532a158a4b8bd2f414128b5213156c150cf58c4c750df54c15809aad150c15f02ab7832bf44dacb002a9d64f01da0f00836828fb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138370, 1760, 1.0, 1.0, 'g', NULL, 2, 'Adult', X'789c4dcc410ac2400c05d0abfc0328a2e06674d72ebaf40a9184129cc984490af6f6baecfef13eca263b72908557b28453aa58c6097dcb5016686bc24a29f01e793e5a19dab94c63aa78deee058dbeb862c55bf98165bebce602eb88cdbd4afbb73f37d627ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138371, 1760, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c4dcc410a02310c05d0abfc03282d0a2eaabb99854b4f20041a24d8a4a5c980737b5dba7fbcb754e31d31c97c34b2c0a010b6f003fa162e9521aa5c858231bac7f1dff2945e0b96b934dcceb940e9834bcefa4afa3ca54afb15f7353dd602ebf06d8cc6fadbbf4ea22a17', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138372, 6335, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492db1563032cd4dd751303500918606400a0001330bfd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138373, 6335, 25.0, 150.0, 'mg', 'PO', 1, 'Adult', X'789c3332d5353435c84d5708f0574849cccca90400263704f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138374, 6335, 0.1, 1.4, 'mg/kg', NULL, 1, 'Pediatric', X'789c33d0335428c95730d43351c84dd7cf4e574849cccca904004087066e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138375, 2292, 250.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c333235d0353530c84d5708f05770f27451a830d53534504849ac2c06005a0c0708', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138376, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Adult', X'789c333235c84d5708f05770f27451a83034504849ac2c06003bf805e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138377, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Adult', X'789c333235c84d5708f05770f27451a83034504849ac2cb656f0cc4bcbb752c8cb2f51284a4dcecfcd4dcd4b494d5128482d52f074097654482fcd4c49cdc9cc4b2d06007b93150a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138378, 2292, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c3d8ccb0dc3200c8657f9074825720d13f4d4ae80c02448184b8e89e8f6253df4fc3d56e71cef78bf30568f67cbb2218ba2b44cd18ab413921149af321674253b342cd0093b7ba41e2a4c291853b35f198f1af893ca04511effcf9d084f2b51fa022b4a29d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138379, 2292, 500.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c333530c84d5708f05770f27451a83032504849ac2c06003bda05e3', X'789ced5c6d6fdb3812fe2b830007a458c7b19da6c53a87031c276db34d52234e8bee9d0b839168891b89d492541aed22fffd86945f2447b66c35db6dbbfa50d72fe4c3e1cc336f94943f775c197b634e42bad3859d3e9dc452dc33fcd4809d5806e64b5feb4875f7f73fb35b1a3685f4cc3bb69f1fab1c4922ea8e8936533aadce8bbd567bafddba6ebdec1eb6baad4eb3d3faf9f98b97762c7534135ce1c83f775e534e2509ec7b4defedf4eb24a25de870173cfbab193de20e8d7c12081509c9f0e38950c4a3f04ac8507541939b80ea0644e2b34b254c8404c67f4b179a8f1d6a49b9a7fdd9705ce3b0157a0d386ce17f478593bbf0321dd36e1ee2ebcbf4d5bc743a87de885f8958530562023d37649c299dcadb85c1bb069c7dc07f1723de176128385c4be252b8446da3c8a840cd7803fecb3871e8a4016f538d5a15c537592d3de0575664f3e97f9ff053c0f8adfdb0d05a4e3f9bd82f3bfce19359a3e7c6811ea3b618f77216299069e78205eede85708d81e8f898389a4a468231e393ecb01904aa7acfea191503c76727707f88fc0097246a27bf3d23c950d3480b47380e220e7c2213ee31cdd4fe35e2b22030ef97e133d0ab817b0eda6b7c41ee110451c743c663b519da119cf189e802171a2475d0a494bbd4850839737632ec81173397a26568d1c2ef39ce8802e6a0b6dcf16bc167bb3b2bd657bb3553d67d7bb672caccd970433a87ca3b76df805852ed4bd23082e9383c0237260120df894629b59de9f8010913176d048ed89be364f75220f7299141323e4f423a3e618a12457362e64dda59a9f72bca71af05d4e20288fb5bacac9c47f0e6a40b1ebba3e00a45814c905460444e14530d543da8388a029a0e1e9c74f35f152cfc8646e8904ef1d21a5c3a41833ddaf81a8fb3a84f4bfe65d7aad95fb3ff5b66ffd3f17399f935416b823e0141bf1e8d96095cf3e847e2d17763cd651ad6e62c326755ad2c6bf70753cbd7dbceb222ff9afd6c8eba799f6d810714b7ab6531f4363df2227c8c3b39900308c55ebb0309060e5c8376e10039b97febed231751992a32fc74d91d3339e9f776c7cf242ecc775d484390197e04bd6076c6614e3c56653a6b520bfd99691fa38e7047fc3fed838c108bfe258b33ef61664886170d8c62e91108dc11c9a8829b6411ff4027110e51f40e15a193952dca3b6db2f5f8c2283c9fb38d820e51b4bf573d2fb6355246579bcaf148bd05926cd3e37d0354dba0a83ada908f5fbc50e1a993dcb2b179acc4ce964a3c5ce83063e5ed775eada759e2047105023818add56cc16949335df189ca9a115fd435f8fe4bcad4a51de4b5f538666d56ebac7195beec07f0ef760b3573682d6da0ada17fef3cf7bf34492ecc2d8d38c0c28830697eb103bf6271b1a4826ae938733a3db7f70647d38bb10f6b4fdbea34ba48a3c52729751eadf3689d47eb3c5ae7d13a8fd6bdd5f63961e3eb137552a893429d14eaa4f0bd26853aa455b9da57c7b43aa6d531eddb8b69dfbb5f56b8aba076ccda31bf7dc7fc11885c7eaf45cde41f9fc94f69f575f797d4667f1ab3ff43fd69fd1d374fa7d96d70b7bceb661851c75ced1b88280ec8e39bee06927a9c7027e9c2f1889f1347cf9ec091e20671131892091d716b7c48051c71fbaccb132b7cc4e777086177bc96504fc6a623f84a6c1af1a98d975578b9b06e4e01975f64f5bee05a12c65d532b3cb2792f08a8f412d0029c8028b56f9e6383dd21453be79e6c42d50ba5f630d3e3d2774c2723fe0c8790d8667636013fc15e5f516e8e3c50355ae01efa97b921cb8acdcf9f2a65c5cf8ab23fb0fa403d2b215d2a733f8624e0312a2b7d4a2db7a229788070cd6e9840f83ddca3402fc0aa091c61db17f099d242165dfcdd28fbad57d3960f908d1fcd4719322edabf2c07348366cfa1dd199b8caf2cdcb2ed0b0f62a864225ee20827919f04e49e29e42af67f82ba3424237e2deed16034c2564ea2098053470aeb05233ed4f40ec9b0f78bf0b94263a884bb528448ab338efea2ccb5133b25f28ddd70c6c0841e2d22ca99c1f671f48dc87cd3f324e17160bfb24b9cd3f876f6e32545fbcf3ebca1218a61c8d4e33434df0c53f6e0a43e6a1a99e2b238442e4d26cc61010a95a105fa9d943e2505e9347dfc30a79c93e9681481c458beec7f1021eec7b8f52f4432e5f87b6fa8bcf7290b314ac8a92146fc03f1184f378e10e698ec8a281f77797edd80def01a6840ef8c3cb3787b96f18b745b956ab58c31cb99941d9ce3e182059b80ccc7e63056b3a71cf3faf4320fb68a6ee5504b33c7c3d9ccbcb04b74dc40c4e5197979a784dc40bed9c8dcfc421a6f106b16d3c68b6939e4930cfdd783cd47e6e6cf895d0eb0183a3d6daa834f36f82cc7e63afad4d1a78e3e7f59f4f9f6dcab4a35fa372ad05c1e080956d5c24b726a7c4382c95ec026e6c8b1f91c7c114bec930e9a87e95bd8b56dddc1e1b3c6885f50dc2216e62aecc205c2a36f1e41ffd7013c3fc4ae2fe6b75c7c460d9fde3b92a6dde97b2c9b894c20923858326c5377df47a6a169b75affc2198e4fb847dd6706dbbc4768fb6726a67f96627a17acc35cb312e33e760a5a814383003e137c0963077d28d218298c636b9f4e83c4968d586fde848c87d33609ffd1f29afc2dcdab7338e2d8f53a46245c6d7fd173edc62a468913dcead9883393ea42db46e24fe6e657dbc367a74ab3158ddd11ceb81af1f947d815d25ecaa5137b768bd80e6e063bc8147df8138a9070ec1c713c86517b7166a1b145bb850ef01e87ce253427cbefafcf407063266e43a5d2c8776771e08cf81fdb238e3db34b34badec70e66c85408ecaf50675234e026d65640f44a37231b8e3e58337a3130b33323d36b29e2087aa0ccf52e8816d7b9207f14eec6a6b385d3264c084520e3e11f9f575971ba12a731069db26c8afe6d2534d67f2d490803912ad44c7b273d4bea3411216a73b69d061c37a0df80d73bb6b89a712eb12353b79fc3ae401acc04a415303e300cf604d566375b5d08f45fc6051217bc22948fed129853e309f6020942cc0c570074b52d0e26b22af25c0c87bd0adab8b82a9c562675bfb75771e6506301d684d3b448c2bc5da4b4b3b2e59bf01bc5c451acab3211ce9b109a8b5b58c798bf61b489d5ac835c528f180751cb80974df01010339fa085a42edb0f02609e66363c146ba4d48e42927b0c96041c0c7028c90a3a96e1bc699ad014c494ff51c93d318a9923b00a33df06f44631b30555c5ada70bef2f60e074787cfe5315977c84f476d0af04647dfbc616032ac22a2d8cfad814781518520815892a11073b62f3f04ab19a379d0c581639f6d26f9108a5d16a480274c195c62e9fef33affaec81149a62b80d992437ac9aa3cc30eee2c033657b350873c70ac7361d54d4ac600df47afc60295a0c501a484d6591b20a2692c6dc6545be5b9a0e32302e33e7c371a5b09e81a9b69f1e3a09128b6079502588f41cc6a95e2f42992e068ac6ee540842656ccb0c5201e83896b7be085cf3381d16c21171581598a1a658344a11f953a1b0fbc106de47de5781fb158d8be527013a2d5cccf50ea708a9cc56af2441ea2bcb5e1d07449ae995a2c9b18c9d354e503aff9c7a4cac73a3529b136c38626911c218d56b3abf2ad997d0d09a26366d0176a349913796eee703bb914c98d0c4d9843985bef808e48229e79143a63756589148b14b9517a609b6ba18a9c3456352545894e25c31e7966aadd89708927ab6396222771b16da3d4e4ce67d5cf599669f8b30710a2bc872d25a51042600acfb25f156e4a152ea497a8799c8328f06f83537456db14796d16fe511dcb67bcb02edda1b0c6668cf2a88f52a5619c3d943550c66b25a9f3430f79eaac52da8b15ae1f328d5a7c7072ef5b9c93fe3dc64dbdb60281df7022576f29799e6aa87dd0bc2f8b3aa07b0c548651729e673c6d3390f9f1e1e1efe0f22e05c62', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138380, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c4d8d3b0e83301044af321788b08d684c95888602912b385a63ac000bb2c3e7f631a2a19c377a3339467e488583352a0e562317a3cbbe2e237320fcc28c770bf2ab274b58a4eab14b815486128dd935a410a7914889e71035549132a2f99ce6abae6e423d75e9c7f9d55ed39b8f3d3a66fa03da7a29dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138381, 2292, 250.0, 500.0, 'mg', 'PO', 2, 'Pediatric', X'789c1dca310a80201406e0abfc0728d0c2a5a0215a9aea0a96cf7048432d7ab74f5a3fbe41b6e0d0610a893a344ad44a88f340d61bd605e33ce155b514309a538fd9db924dc915cc1d7576c1e3d1d151c2c670ded2fe5be6ab94440f4597f90311982113', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138382, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c4dcc3d0e83301403e0abf8021549104b985ab13020b842d00b216ae92b4af8bb3d412c1d6debb3c2c48f0207a3e260357231b9eced323207c2127ee85a905f3d59c22cd5885d0aa4319468ccae2185b8446a4a3c3f51431529239afe92afbafa03f577600de7577b5f6f3e8e1898e904a24d2974', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138383, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c558d3d0e84201844af32173002c62db072636361f40a6c3e44b22a1af0eff68bd9ca72dee4cdbc122e703989ca792d91b1c9a45f9392bae037bfa06b4176b7a4092b1703ce3ce10cb1f6051a754a70c66e279202e51824441e3382fadceebbae1e4a3df7f1cbd85dffe70f1b06f4ced10fe08b29a8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138384, 2292, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c4d8d410e82301045aff22f6068216eca0ac38685c1c413a01d4a23ed202d08b7b7c48dcbf9f3df7f051c9f648e9d156a0ea4500867b297c974b7232c61c2ad85b6abd5a4f196f9804d0aa4672871ed360529c441a4a444354685fc9c6ec4ee719097a6fe031adf278fe788999eec1cf96375a2194d7daf60966419ada7543576a59fff63e3809e597f01dbd3371d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138385, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Pediatric', X'789c0dca410a80201005d0abfc2368d1a62028dcb82ae804d64c22a4861ae4edebaddf285bd4d843c5cc3d9a4e788b6276ac0b66adf04a0132350fd0e1fc5b8805898fe83d0762c2cd095a6d13ece3882f17387ff9991a4a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138386, 2292, 20.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c158c4d0e40301406aff25d40fa2336b5b5b110ae2079558dd423a5f4f66a3b93991a812ba591d9a0e3680db40c4e6c4ed09c11ef78601a413e79b28453e915af922832b618e6d7a0917f50408b7e5fcac6f964f1f86bc5c24c1fb16f1eb5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138387, 2292, 250.0, 250.0, 'mg', 'PO', 2, 'Pediatric', X'789cb3333456a8ccb75270c92f4eb552303235c84d5728494c5208f05770f27451a83034504849ac2c0600d82f0b24', X'789ced5c6d6fdb3812fe2b830007a458c7b19da6c53a87031c276db34d52234e8bee9d0b839168891b89d492541aed22fffd86945f2447b66c35db6dbbfa50d72fe4c3e1cc336f94943f775c197b634e42bad3859d3e9dc452dc33fcd4809d5806e64b5feb4875f7f73fb35b1a3685f4cc3bb69f1fab1c4922ea8e8936533aadce8bbd567bafddba6ebdec1eb6baad4eb3d3faf9f98b97762c7534135ce1c83f775e534e2509ec7b4defedf4eb24a25de870173cfbab193de20e8d7c12081509c9f0e38950c4a3f04ac8507541939b80ea0644e2b34b254c8404c67f4b179a8f1d6a49b9a7fdd9705ce3b0157a0d386ce17f478593bbf0321dd36e1ee2ebcbf4d5bc743a87de885f8958530562023d37649c299dcadb85c1bb069c7dc07f1723de176128385c4be252b8446da3c8a840cd7803fecb3871e8a4016f538d5a15c537592d3de0575664f3e97f9ff053c0f8adfdb0d05a4e3f9bd82f3bfce19359a3e7c6811ea3b618f77216299069e78205eede85708d81e8f898389a4a468231e393ecb01904aa7acfea191503c76727707f88fc0097246a27bf3d23c950d3480b47380e220e7c2213ee31cdd4fe35e2b22030ef97e133d0ab817b0eda6b7c41ee110451c743c663b519da119cf189e802171a2475d0a494bbd4850839737632ec81173397a26568d1c2ef39ce8802e6a0b6dcf16bc167bb3b2bd657bb3553d67d7bb672caccd970433a87ca3b76df805852ed4bd23082e9383c0237260120df894629b59de9f8010913176d048ed89be364f75220f7299141323e4f423a3e618a12457362e64dda59a9f72bca71af05d4e20288fb5bacac9c47f0e6a40b1ebba3e00a45814c905460444e14530d543da8388a029a0e1e9c74f35f152cfc8646e8904ef1d21a5c3a41833ddaf81a8fb3a84f4bfe65d7aad95fb3ff5b66ffd3f17399f935416b823e0141bf1e8d96095cf3e847e2d17763cd651ad6e62c326755ad2c6bf70753cbd7dbceb222ff9afd6c8eba799f6d810714b7ab6531f4363df2227c8c3b39900308c55ebb0309060e5c8376e10039b97febed231751992a32fc74d91d3339e9f776c7cf242ecc775d484390197e04bd6076c6614e3c56653a6b520bfd99691fa38e7047fc3fed838c108bfe258b33ef61664886170d8c62e91108dc11c9a8829b6411ff4027110e51f40e15a193952dca3b6db2f5f8c2283c9fb38d820e51b4bf573d2fb6355246579bcaf148bd05926cd3e37d0354dba0a83ada908f5fbc50e1a993dcb2b179acc4ce964a3c5ce83063e5ed775eada759e2047105023818add56cc16949335df189ca9a115fd435f8fe4bcad4a51de4b5f538666d56ebac7195beec07f0ef760b3573682d6da0ada17fef3cf7bf34492ecc2d8d38c0c28830697eb103bf6271b1a4826ae938733a3db7f70647d38bb10f6b4fdbea34ba48a3c52729751eadf3689d47eb3c5ae7d13a8fd6bdd5f63961e3eb137552a893429d14eaa4f0bd26853aa455b9da57c7b43aa6d531eddb8b69dfbb5f56b8aba076ccda31bf7dc7fc11885c7eaf45cde41f9fc94f69f575f797d4667f1ab3ff43fd69fd1d374fa7d96d70b7bceb661851c75ced1b88280ec8e39bee06927a9c7027e9c2f1889f1347cf9ec091e20671131892091d716b7c48051c71fbaccb132b7cc4e777086177bc96504fc6a623f84a6c1af1a98d975578b9b06e4e01975f64f5bee05a12c65d532b3cb2792f08a8f412d0029c8028b56f9e6383dd21453be79e6c42d50ba5f630d3e3d2774c2723fe0c8790d8667636013fc15e5f516e8e3c50355ae01efa97b921cb8acdcf9f2a65c5cf8ab23fb0fa403d2b215d2a733f8624e0312a2b7d4a2db7a229788070cd6e9840f83ddca3402fc0aa091c61db17f099d242165dfcdd28fbad57d3960f908d1fcd4719322edabf2c07348366cfa1dd199b8caf2cdcb2ed0b0f62a864225ee20827919f04e49e29e42af67f82ba3424237e2deed16034c2564ea2098053470aeb05233ed4f40ec9b0f78bf0b94263a884bb528448ab338efea2ccb5133b25f28ddd70c6c0841e2d22ca99c1f671f48dc87cd3f324e17160bfb24b9cd3f876f6e32545fbcf3ebca1218a61c8d4e33434df0c53f6e0a43e6a1a99e2b238442e4d26cc61010a95a105fa9d943e2505e9347dfc30a79c93e9681481c458beec7f1021eec7b8f52f4432e5f87b6fa8bcf7290b314ac8a92146fc03f1184f378e10e698ec8a281f77797edd80def01a6840ef8c3cb3787b96f18b745b956ab58c31cb99941d9ce3e182059b80ccc7e63056b3a71cf3faf4320fb68a6ee5504b33c7c3d9ccbcb04b74dc40c4e5197979a784dc40bed9c8dcfc421a6f106b16d3c68b6939e4930cfdd783cd47e6e6cf895d0eb0183a3d6daa834f36f82cc7e63afad4d1a78e3e7f59f4f9f6dcab4a35fa372ad05c1e080956d5c24b726a7c4382c95ec026e6c8b1f91c7c114bec930e9a87e95bd8b56dddc1e1b3c6885f50dc2216e62aecc205c2a36f1e41ffd7013c3fc4ae2fe6b75c7c460d9fde3b92a6dde97b2c9b894c20923858326c5377df47a6a169b75affc2198e4fb847dd6706dbbc4768fb6726a67f96627a17acc35cb312e33e760a5a814383003e137c0963077d28d218298c636b9f4e83c4968d586fde848c87d33609ffd1f29afc2dcdab7338e2d8f53a46245c6d7fd173edc62a468913dcead9883393ea42db46e24fe6e657dbc367a74ab3158ddd11ceb81af1f947d815d25ecaa5137b768bd80e6e063bc8147df8138a9070ec1c713c86517b7166a1b145bb850ef01e87ce253427cbefafcf407063266e43a5d2c8776771e08cf81fdb238e3db34b34badec70e66c85408ecaf50675234e026d65640f44a37231b8e3e58337a3130b33323d36b29e2087aa0ccf52e8816d7b9207f14eec6a6b385d3264c084520e3e11f9f575971ba12a731069db26c8afe6d2534d67f2d490803912ad44c7b273d4bea3411216a73b69d061c37a0df80d73bb6b89a712eb12353b79fc3ae401acc04a415303e300cf604d566375b5d08f45fc6051217bc22948fed129853e309f6020942cc0c570074b52d0e26b22af25c0c87bd0adab8b82a9c562675bfb75771e6506301d684d3b448c2bc5da4b4b3b2e59bf01bc5c451acab3211ce9b109a8b5b58c798bf61b489d5ac835c528f180751cb80974df01010339fa085a42edb0f02609e66363c146ba4d48e42927b0c96041c0c7028c90a3a96e1bc699ad014c494ff51c93d318a9923b00a33df06f44631b30555c5ada70bef2f60e074787cfe5315977c84f476d0af04647dfbc616032ac22a2d8cfad814781518520815892a11073b62f3f04ab19a379d0c581639f6d26f9108a5d16a480274c195c62e9fef33affaec81149a62b80d992437ac9aa3cc30eee2c033657b350873c70ac7361d54d4ac600df47afc60295a0c501a484d6591b20a2692c6dc6545be5b9a0e32302e33e7c371a5b09e81a9b69f1e3a09128b6079502588f41cc6a95e2f42992e068ac6ee540842656ccb0c5201e83896b7be085cf3381d16c21171581598a1a658344a11f953a1b0fbc106de47de5781fb158d8be527013a2d5cccf50ea708a9cc56af2441ea2bcb5e1d07449ae995a2c9b18c9d354e503aff9c7a4cac73a3529b136c38626911c218d56b3abf2ad997d0d09a26366d0176a349913796eee703bb914c98d0c4d9843985bef808e48229e79143a63756589148b14b9517a609b6ba18a9c3456352545894e25c31e7966aadd89708927ab6396222771b16da3d4e4ce67d5cf599669f8b30710a2bc872d25a51042600acfb25f156e4a152ea497a8799c8328f06f83537456db14796d16fe511dcb67bcb02edda1b0c6668cf2a88f52a5619c3d943550c66b25a9f3430f79eaac52da8b15ae1f328d5a7c7072ef5b9c93fe3dc64dbdb60281df7022576f29799e6aa87dd0bc2f8b3aa07b0c548651729e673c6d3390f9f1e1e1efe0f22e05c62', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138388, 2292, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Pediatric', X'789c15cc310e80200c46e1abfc07708015571727bd42c5a2244293528cc757e797efd12e17b7c8d55ac0248d03bc73ae1c30dab02e78fc88b9260948a2c83571b42cb5411222eb9d9f015dd94ea501fac55e46ec9d2e983259f9cebf7c013b1b2448', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138389, 2292, 500.0, 500.0, 'mg', 'PO', 2, 'Pediatric', X'789cb3333456a8ccb75270c92f4eb552303530c84d5728494c5208f05770f27451a83032504849ac2c0600d8090b23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138390, 2292, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c55ca4b0e40301405d0addc0510ea3369cd1898b185269e6ab45a1e12bb676a7a724af8908a024f90688fd6a111b984a8bdc9568371005f1cb117d5a2d07712c6de84293041cf271d98ac760f5b4eb085efc6e8c8d3762a8c5ffed10bacd72275', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138391, 2292, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c55ca4b0e40301405d0addc0510ea3369cd1898b185269e6ab45a1e12bb676a7a724af8908a024f90688fd6a111b984a8bdc9568371005f1cb117d5a2d07712c6de84293041cf271d98ac760f5b4eb085efc6e8c8d3762a8c5ffed10bacd72275', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138392, 11915, 200.0, 1000.0, 'mg', NULL, 1, 'Adult', X'789c15c6410a80300c04c0afec510f42f447c5ac5ad0a4a411f1f7e29c6611996611b97668a9e78b41bd13ca46d30e37ec34cfb711c514abdb7a47d012192c79fd7b6a1ea8968c8de1367eaf361e11', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138393, 11915, 15.0, 15.0, 'mg/kg', NULL, 1, 'Pediatric', X'789cf3482d5070b652b03352a84c4d2c2a56c8cf49b1523034cd4dd7cf4e574849cccca90400b15a0ab6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138394, 11915, 400.0, 1200.0, 'mg', NULL, 1, 'Pediatric', X'789c333130d035343230c84d574849cccca904002008048c', X'789ced58ef6bf33610fe578e7c7a0b499ba4ebd68531c8d29515d636a4a11bcc2f46b12fb6a82c19496e9bbe747ffb4eb6e3446987f306c618eb97104bcf3d92ee9e3bfdf8d2897591849265d8194167c617ec916b2e3b5de8145ab8b6d4dadc8c4e4e9ef80366c74a27ee1f3ff1a026d22cc73864d6590cfbc36f7bfd416fd09ff7cf47fdc168787e3c381b7e7f7a5a6231b25c4943c82f9d719c71c98dd5ccb5954d169f4b96f92ac75120c7d2721a878940f6e0f2620c2ccfb57ac418964a07f217ccc9d47203934076c1e0236a0ce4ecee3e905c2eabb18ee176b9ec09b640018571ac29ea1c0d189ee5029fc9b2448b02e50b2bbfca2121c54c699db28447b074d481bc50862508974a676604c37e1f2c5b74cb3f11cb6964555862564bf0d736825b62ec02972913654b20272acb9484b96631c20dc58018272ac7a4305d98e102ad220be76993d38cb1745fb1d8f6e02b35d10404baaf3f3ed397e0f2a1fcd8b8b2f1617b58375062de306cb9b99da30187139f85a2b287b008e459f9b1da6778870fd7788fab09723bcd5503f518fe4618ed7cf7ce30dc320c2bc3d7cf2e86e3b8103624717199786940c2a244eaf7b30462c6c50a3ec5ca20c498a38c4967121294ca52b2009331444a4685d6282d588dcc66eedf13b72909cfa25ea256f2e8eb7454ce6f8a316756d3acdf9923051c2623f871082b649a2625e2110cceb2e4e4a19e75206f6781fcc6ad65b8594b99a7f0a94a5a4a1f83e6c8e51419660218cdd528c15f28d729e1350c86bdc139a4aaa0219ee1b4f71db1accc018bb9cb31e2148ca9ca8b2a178db79ea9c6443219ad6046bd3209287b7f0fe4af2cb2251a34370fae9134c2c8bfee93a62f290eb040d08570532e2cad0f25a9252e5d36028d711151978ba071f50b322ee25ea662a42281408a655cbb907509038e8eca15f0254cf444c00f67fd432bc0ee8adae57ae1f6850a6c422ec386c14f07df27edb40d3e74f830a265274a739a7c95071325a9607219f3e89dc08c85409dacc02a880433e6c4ed5eb4471456f12c2b245262d6b5c75557e655e02a0d621e33e9e2816ef3c85422d4824b455629e5161e27c781b4ae441b8319af3603c3a30741024541bbd051206b5f507c2984b9b214309213e5665e77c093a22876817ee0295590b1950b6ed94b7136d4abdc042a796cc20e9fd681feca1cdd72d13bbed8a3ec3756e1c6ca0bf4964fdae9e65b608f65cb93ed2c7725382cc11ecbdaffed140d725d65a98e180c67c8a2b7ea7ac7e59d3bd45c1566a7dc654aac2c957e261b8dcce7d340fe44b464e0529e1ba47a561f509455cf3ce2962adef55520ef0afa88cbed7c2b9e95fcdd89c01bed060babe95020dd40378c0a427d425119af8a137d5071a65dc5f58c8d4d1db66c7c79219d1b53429614d5a4a019fd863c492d08e53aa6bad0dc1666772e7b696dd711fbeccdb545585b7871251feea12d0279566f9cdeced198846b93b7a79d26667b1e7836788febfaaadd9e309ecd963e5a32a4067ad65b826967d806fb2ca5d2f620a870fe19a996e61e87a235d2b35fab798f5d6a8ddcb1af85bf0fc11aea31d4c9d26e7f590377ead326a9daea538dacead33f5d6d76abdb47b9f928371fe5e67f5b6efed5f43fe470fba1b5ffacd6a629d3198b9450c9cadfdf9858f6045fe208fe3cedf7abfb3ded5c486aa0dbbfc94681fcf939d258bda25d2b63e9a6a5ddcde980abff354629a33b6116aa65388edebc3a36fde5edfb89ae1e5048ba9e1bab547cc85303623816467983dcd76f48cd5575e779ed90d4d8e1dcff3deadddbdee1ef7db497bffe05b230a2cf', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138395, 11915, 20.0, 20.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b0a0e53d0284e2d4b2d4a55484e2c4e2dd6b4523032c84dd7cfcd51484c2dca2fcecfc9ac4a4d51c807aa503034d235b450c8c82f2d2a56a85030d635574849ac2c0600f1f415e5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (138396, 8041, 800.0, 800.0, 'mg', NULL, NULL, 'Adult', X'789cb3303050c84d57283434ca2852a850304d010027fb04ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);